Results 181 to 190 of about 15,494 (292)

Immunohistochemical biomarkers for risk stratification of neoplastic progression in Barrett esophagus [PDF]

, 2016
Vincent T. Janmaat, Sophie H. van Olphen, Katharina Biermann, Leendert H. J. Looijenga, Marco J. Bruno, Manon C.W. Spaander   +5 more
openalex   +1 more source

Most Siewert type II esophagogastric junction adenocarcinomas in Chinese patients lack a Barrett esophagus background

, 2023
Weiwei Tan, Chun-sheng Cheng, Kai-Xin Wang, Mu‐Xian Lin, Shaoxiong Liu, Ling-Ling Kang, Hou‐De Zhang   +6 more
openalex   +1 more source

A Newly Identified Susceptibility Locus near FOXP1 Modifies the Association of Gastroesophageal Reflux with Barrett's Esophagus [PDF]

, 2015
1000 Genomes Project, Anna H. Wu, Banham, Banham, Benjamini, Brian J. Reid, Cook, David C. Whiteman, David M. Levine, Douglas A. Corley, Engel, Harvey A. Risch, James Y. Dai, Jean de Dieu Tapsoba, Jesper Lagergren, Lagergren, Laura J. Hardie, Leslie Bernstein, Lynn E. Onstad, Matthew F. Buas, Nicholas J. Shaheen, Nigel C. Bird, Reid, Stavrou, Thomas L. Vaughan, Weimin Ye, Wong-Ho Chow, Zhai   +27 more
core   +2 more sources

eQTL Set-Based Association Analysis Identifies Novel Susceptibility Loci for Barrett Esophagus and Esophageal Adenocarcinoma. [PDF]

Cancer Epidemiol Biomarkers Prev, 2022
Wang X, Gharahkhani P, Levine DM, Fitzgerald RC, Gockel I, Corley DA, Risch HA, Bernstein L, Chow WH, Onstad L, Shaheen NJ, Lagergren J, Hardie LJ, Wu AH, Pharoah PDP, Liu G, Anderson LA, Iyer PG, Gammon MD, Caldas C, Ye W, Barr H, Moayyedi P, Harrison R, Watson RGP, Attwood S, Chegwidden L, Love SB, MacDonald D, deCaestecker J, Prenen H, Ott K, Moebus S, Venerito M, Lang H, Mayershofer R, Knapp M, Veits L, Gerges C, Weismüller J, Reeh M, Nöthen MM, Izbicki JR, Manner H, Neuhaus H, Rösch T, Böhmer AC, Hölscher AH, Anders M, Pech O, Schumacher B, Schmidt C, Schmidt T, Noder T, Lorenz D, Vieth M, May A, Hess T, Kreuser N, Becker J, Ell C, Tomlinson I, Palles C, Jankowski JA, Whiteman DC, MacGregor S, Schumacher J, Vaughan TL, Buas MF, Dai JY.   +69 more
europepmc   +1 more source

Screening for Barrett’s esophagus: Balancing clinical value and cost-effectiveness [PDF]

, 2019
Gyawali, C Prakash, Patel, Amit
core   +1 more source

Spatiotemporal Study of a Risk-Stratification Epigenetic-Based Biomarker Assay in Patients With Barrett Esophagus. [PDF]

Am J Gastroenterol
Laun SE, Laun SE, Kann L, Braun J, Pierre F, Kim S, Gilbert S, Lunz D, Kalra A, Ma K, Cheng Y, Leggett CL, Zaidi AH, Omstead AN, Korman L, Jobe B, Perpetua L, Greenwald BD, Maddala T, Meltzer SJ.   +19 more
europepmc   +1 more source

Table of Contents

United European Gastroenterology Journal, Volume 13, Issue S8, Page S5-S6, October 2025.
wiley   +1 more source

Validation of an Epigenetic Prognostic Assay to Accurately Risk-Stratify Patients With Barrett Esophagus. [PDF]

Am J Gastroenterol
Laun SE, Laun SE, Kann L, Braun J, Gilbert S, Lunz D, Pierre F, Kalra A, Ma K, Tsai HL, Wang H, Jit S, Cheng Y, Ahmed Y, Wang KK, Leggett CL, Cellini A, Ioffe OB, Zaidi AH, Omstead AN, Jobe B, Korman L, Cornish D, Zellenrath P, Spaander M, Kuipers E, Perpetua L, Greenwald BD, Maddala T, Meltzer SJ.   +29 more
europepmc   +1 more source

UEG Week 2025 Oral Presentations

United European Gastroenterology Journal, Volume 13, Issue S8, Page S7-S188, October 2025.
wiley   +1 more source

ADENOCARCINOMA AND DYSPLASIA IN BARRETT ESOPHAGUS: CRITICAL ANALYSIS OF RISK FACTORS AND SURVEILLANCE PROTOCOLS. [PDF]

Arq Bras Cir Dig
Gallon E, Szachnowicz S, Duarte AF, Tustumi F, Sallum RAA, Herman P, Ribeiro Junior U.   +6 more
europepmc   +1 more source